OSCR
Oscar Health, Inc. NYSE Listed Mar 3, 2021$28.40
+0.46%
vs $28.27
Mkt Cap $7.4B
52w Low $10.69
92.6% of range
52w High $29.81
50d MA $21.33
200d MA $17.37
P/E (TTM)
-16.8x
EV/EBITDA
—
P/B
7.6x
Debt/Equity
0.4x
ROE
-45.3%
P/FCF
7.0x
RSI (14)
71.30
ATR (14)
$1.82
Beta
1.93
50d MA
$21.33
200d MA
$17.37
Avg Volume
8.2M
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
75 Varick Street · New York City, NY 10013 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | TNS | 1.11 | 2.07 | +86.5% | 19.84 | -0.3% | +5.2% | +2.1% | +3.2% | +7.9% | -0.5% | — |
| Feb 10, 2026 | TNS | -0.92 | -1.24 | -34.6% | 12.88 | +2.5% | +5.6% | +0.8% | -2.1% | -0.2% | +2.3% | — |
| Nov 6, 2025 | TNS | -0.55 | -0.53 | +3.6% | 16.56 | -0.8% | +7.0% | -17.6% | +1.6% | +1.7% | -7.6% | — |
| Aug 6, 2025 | TNS | -0.90 | -0.89 | +1.1% | 14.34 | +0.9% | +5.7% | +2.0% | +1.0% | -4.0% | -0.3% | — |
| May 7, 2025 | TNS | 0.83 | 0.92 | +10.8% | 17.02 | +3.2% | +0.2% | +0.3% | -1.7% | +0.6% | -2.2% | — |
| Feb 4, 2025 | TNS | -0.55 | -0.62 | -12.7% | 15.28 | -1.7% | +3.1% | -6.2% | -0.5% | +0.1% | -4.1% | — |
| Nov 7, 2024 | TNS | -0.20 | -0.22 | -10.0% | 13.64 | -0.2% | -0.7% | +1.9% | -1.7% | -0.6% | +14.5% | — |
| Aug 7, 2024 | TNS | 0.16 | 0.20 | +25.0% | 16.70 | +1.9% | +10.6% | -2.3% | -0.4% | +1.7% | -0.4% | — |
| May 7, 2024 | TNS | 0.27 | 0.62 | +129.6% | 19.77 | -0.6% | +4.9% | +6.9% | -2.4% | +1.4% | +4.0% | — |
| Feb 7, 2024 | TNS | -0.74 | -0.66 | +10.8% | 13.41 | +30.0% | +24.4% | +6.0% | -2.0% | -2.9% | +0.4% | — |
| Nov 7, 2023 | TNS | -0.47 | -0.29 | +38.3% | 6.62 | +3.0% | +6.5% | -4.3% | +5.3% | -4.4% | +5.7% | — |
| Aug 8, 2023 | TNS | -0.33 | -0.07 | +78.8% | 7.13 | +8.6% | +12.1% | -8.4% | +2.5% | -7.5% | +8.9% | — |
| May 9, 2023 | BMO | -0.05 | -0.18 | -254.6% | 7.14 | +3.2% | -3.9% | +1.6% | +0.7% | +2.3% | -4.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 | Barclays | Upgrade | Equal Weight → Overweight | $35 | $27.22 | $28.80 | +5.8% | +2.3% | +3.8% | -2.2% | +3.1% | -2.0% |
| Jun 4 | Wells Fargo | Upgrade | Underweight → Equal Weight | $20 | $20.50 | $22.25 | +8.5% | +15.1% | +3.9% | +11.8% | -0.6% | +2.3% |
| May 6 | Wolfe Research | Initiates | Peer Perform | — | $17.94 | $18.44 | +2.8% | +10.6% | +5.2% | +2.1% | +3.2% | +7.9% |
| Apr 20 | Jefferies | Upgrade | Underperform → Hold | — | $15.79 | $16.08 | +1.8% | +4.1% | -1.6% | +1.7% | -0.1% | +2.3% |
| Jan 9 | UBS | Upgrade | Sell → Neutral | — | $16.90 | $18.01 | +6.6% | +4.9% | -0.4% | -1.6% | -4.0% | +4.4% |
| Jan 5 | Barclays | Upgrade | Underweight → Equal Weight | — | $14.97 | $15.65 | +4.5% | +10.7% | -0.3% | -0.2% | +2.5% | +4.9% |
| Nov 26 | Piper Sandler | Upgrade | Neutral → Overweight | — | $16.73 | $17.59 | +5.1% | +8.5% | -1.0% | -7.3% | +1.2% | +1.5% |
| Nov 13 | Wells Fargo | Maintains | Underweight → Underweight | — | $15.10 | $14.80 | -2.0% | -7.6% | -0.5% | +2.7% | +3.2% | -4.3% |
| Nov 10 | Barclays | Maintains | Underweight → Underweight | — | $17.72 | $16.13 | -9.0% | -17.6% | +1.6% | +1.7% | -7.6% | -0.5% |
| Nov 7 | UBS | Maintains | Sell → Sell | — | $16.56 | $16.42 | -0.8% | +7.0% | -17.6% | +1.6% | +1.7% | -7.6% |
| Oct 7 | Wells Fargo | Maintains | Underweight → Underweight | — | $22.31 | $23.55 | +5.6% | +0.7% | -3.0% | -5.8% | -8.6% | +8.7% |
| Aug 14 | Piper Sandler | Maintains | Neutral → Neutral | — | $14.93 | $14.64 | -1.9% | -1.7% | +6.5% | +6.5% | -0.1% | -8.2% |
| Jul 25 | Baird | Downgrade | Outperform → Neutral | — | $14.20 | $14.28 | +0.6% | +1.8% | +1.5% | -5.7% | +1.2% | +0.4% |
| Jul 23 | Barclays | Maintains | Underweight → Underweight | — | $14.70 | $14.24 | -3.1% | +8.0% | -10.5% | +1.8% | +1.5% | -5.7% |
| Jul 15 | UBS | Downgrade | Neutral → Sell | — | $15.08 | $14.62 | -3.1% | -1.1% | +2.9% | -9.6% | -3.2% | +1.5% |
| Jul 11 | Wells Fargo | Downgrade | Equal Weight → Underweight | — | $15.53 | $14.99 | -3.5% | -7.4% | +4.9% | -1.1% | +2.9% | -9.6% |
| Jun 9 | Piper Sandler | Maintains | Overweight → Overweight | — | $15.42 | $15.50 | +0.5% | -4.3% | -0.5% | -3.7% | +1.3% | -2.7% |
| Mar 13 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $14.19 | $13.60 | -4.2% | -9.2% | +2.6% | +1.7% | -4.6% | +0.2% |
| Nov 6 | BofA Securities | Downgrade | Neutral → Underperform | — | $18.34 | $15.79 | -13.9% | -15.2% | -12.3% | -0.7% | +1.9% | -1.7% |
| Sep 10 | Piper Sandler | Maintains | Overweight → Overweight | — | $17.47 | $18.00 | +3.0% | -0.3% | +18.7% | +1.6% | +2.9% | +1.4% |
| Aug 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $16.70 | $17.01 | +1.9% | +10.6% | -2.3% | -0.4% | +1.7% | -0.4% |
| Jul 10 | Piper Sandler | Maintains | Overweight → Overweight | — | $15.75 | $15.87 | +0.8% | +4.1% | +1.2% | -0.4% | -3.1% | +1.2% |
| Jun 12 | Wells Fargo | Maintains | Overweight → Overweight | — | $20.01 | $20.60 | +2.9% | -4.7% | -0.3% | +0.0% | -1.1% | +2.3% |
| May 30 | BofA Securities | Downgrade | Buy → Neutral | — | $20.18 | $19.49 | -3.4% | -1.6% | +0.6% | -3.8% | -1.4% | +4.0% |
| May 20 | BofA Securities | Maintains | Buy → Buy | — | $22.52 | $22.51 | -0.0% | -2.3% | +5.8% | -4.6% | -5.7% | -1.9% |
| May 9 | Wells Fargo | Maintains | Overweight → Overweight | — | $20.74 | $21.19 | +2.2% | +6.9% | -2.4% | +1.4% | +4.0% | -0.8% |
| May 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $20.74 | $21.19 | +2.2% | +6.9% | -2.4% | +1.4% | +4.0% | -0.8% |
| Feb 15 | Wells Fargo | Maintains | Overweight → Overweight | — | $16.89 | $17.07 | +1.1% | +8.1% | -2.7% | -1.5% | -3.1% | -1.4% |
| Feb 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $16.68 | $16.49 | -1.1% | +6.0% | -2.0% | -2.9% | +0.4% | +8.1% |
| Feb 8 | BofA Securities | Maintains | Buy → Buy | — | $13.41 | $17.43 | +30.0% | +24.4% | +6.0% | -2.0% | -2.9% | +0.4% |
| Nov 2 | BofA Securities | Upgrade | Neutral → Buy | — | $4.98 | $5.73 | +15.1% | +10.6% | +4.0% | -0.3% | +15.9% | +6.5% |
| Aug 30 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $6.38 | $6.45 | +1.1% | -0.5% | -1.3% | +4.9% | -3.5% | +1.1% |
| Aug 10 | Goldman Sachs | Maintains | Neutral → Neutral | — | $7.99 | $7.89 | -1.3% | -8.4% | +2.5% | -7.5% | +8.9% | -2.2% |
| Aug 9 | Credit Suisse | Maintains | Outperform → Outperform | — | $7.13 | $7.74 | +8.6% | +12.1% | -8.4% | +2.5% | -7.5% | +8.9% |
| Jul 14 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $7.40 | $7.42 | +0.3% | +6.1% | +5.7% | +0.2% | +0.4% | -0.8% |
| Jun 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $9.25 | $9.53 | +3.0% | +4.0% | -5.0% | +4.7% | -7.5% | +0.1% |
| Jun 6 | BofA Securities | Upgrade | Underperform → Neutral | — | $8.30 | $8.40 | +1.2% | +7.1% | +0.1% | -0.4% | +3.8% | +0.5% |
| May 17 | Wells Fargo | Maintains | Overweight → Overweight | — | $6.85 | $6.99 | +2.0% | +6.6% | -0.1% | -1.4% | +4.0% | -2.1% |
| May 10 | Credit Suisse | Maintains | Outperform → Outperform | — | $7.14 | $7.37 | +3.2% | -3.9% | +1.6% | +0.7% | +2.3% | -4.6% |
| Mar 29 | BofA Securities | Maintains | Underperform → Underperform | — | $5.61 | $5.65 | +0.7% | +14.1% | +3.4% | -1.2% | +3.1% | -3.3% |
| Feb 14 | TD Cowen | Maintains | Market Perform → Market Perform | — | $5.29 | $5.24 | -0.9% | +5.3% | +2.3% | -1.6% | -0.2% | -5.9% |
| Feb 14 | Goldman Sachs | Maintains | Neutral → Neutral | — | $5.29 | $5.24 | -0.9% | +5.3% | +2.3% | -1.6% | -0.2% | -5.9% |
| Feb 10 | Credit Suisse | Maintains | Outperform → Outperform | — | $3.80 | $3.90 | +2.6% | +30.3% | +6.9% | +5.3% | +2.3% | -1.6% |
| Nov 16 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $2.89 | $3.05 | +5.5% | +0.3% | -4.1% | +3.2% | +2.1% | -8.2% |
| Nov 14 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $2.95 | $2.97 | +0.7% | -4.1% | +2.1% | +0.3% | -4.1% | +3.2% |
| Sep 1 | Morgan Stanley | Maintains | Overweight → Overweight | — | $6.63 | $6.46 | -2.6% | -7.8% | -4.6% | -5.3% | +3.8% | +1.2% |
| Jun 15 | BofA Securities | Downgrade | Neutral → Underperform | — | $4.19 | $4.00 | -4.5% | +1.7% | -4.7% | +8.4% | -1.1% | +0.2% |
| Jun 9 | Morgan Stanley | Maintains | Overweight → Overweight | — | $5.22 | $5.15 | -1.3% | -6.3% | -6.5% | -5.9% | -2.6% | +1.7% |
| May 26 | BofA Securities | Downgrade | Buy → Neutral | — | $5.06 | $4.75 | -6.1% | -5.5% | +6.1% | -4.5% | -2.9% | +6.2% |
| Mar 28 | Morgan Stanley | Maintains | Overweight → Overweight | — | $9.54 | $9.48 | -0.6% | -4.8% | +11.9% | +0.9% | -2.7% | +1.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Blackley Richard ScottOff | Chief Financial Officer | Sell | 8,977 | $22.45 | $202K | 1,074,977 | +3.86% | +3.81% |
| Jun 2, 2026 | Blackley Richard ScottOff | Chief Financial Officer | Sell | 22,706 | $21.74 | $494K | 1,083,954 | +3.86% | +3.81% |
| Jun 2, 2026 | McAnaney AdamOff | Chief Legal Officer | Sell | 2,794 | $22.45 | $63K | 218,096 | +3.86% | +3.81% |
| Jun 2, 2026 | McAnaney AdamOff | Chief Legal Officer | Sell | 7,065 | $21.74 | $154K | 220,890 | +3.86% | +3.81% |
| Jun 2, 2026 | Schlosser MarioDir | — | Sell | 9,668 | $22.45 | $217K | 480,866 | +3.86% | +3.81% |
| Jun 2, 2026 | Schlosser MarioDir | — | Sell | 24,452 | $21.74 | $532K | 490,534 | +3.86% | +3.81% |
| Jun 2, 2026 | Liang JanetOff | President, Oscar Insurance | Sell | 3,535 | $22.45 | $79K | 259,057 | +3.86% | +3.81% |
| Jun 2, 2026 | Liang JanetOff | President, Oscar Insurance | Sell | 8,940 | $21.74 | $194K | 262,592 | +3.86% | +3.81% |
| Jun 2, 2026 | Baltrus VictoriaOff | Chief Accounting Officer | Sell | 432 | $22.45 | $10K | 214,589 | +3.86% | +3.81% |
| Jun 2, 2026 | Baltrus VictoriaOff | Chief Accounting Officer | Sell | 1,091 | $21.74 | $24K | 215,021 | +3.86% | +3.81% |
| May 18, 2026 | Blackley Richard ScottOff | Chief Financial Officer | Sell | 110,000 | $25.03 | $2.8M | 1,106,660 | -5.47% | +1.55% |
| May 14, 2026 | Blackley Richard ScottOff | Chief Financial Officer | Sell | 8,741 | $23.79 | $208K | 1,216,660 | -3.08% | -3.31% |
| May 14, 2026 | Blackley Richard ScottOff | Chief Financial Officer | Sell | 91,259 | $23.10 | $2.1M | 1,225,401 | -3.08% | -3.31% |
8-K
Oscar Health, Inc. -- 8-K Filing
Oscar Health filed an 8-K indicating compliance assessment updates regarding emerging growth company status under Exchange Act regulations, potentially affecting investor disclosure requirements and regulatory obligations.
Jun 9
8-K · 7.01
! Medium
Oscar Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
Oscar Health will reaffirm its full year 2026 guidance at an upcoming conference, with details available via webcast on its investor relations website.
Jun 8
8-K · 5.02
!!! Very High
Oscar Health, Inc. -- 8-K 5.02: Executive Change
Jun 2
8-K · 2.02
!! High
Oscar Health, Inc. -- 8-K 2.02: Earnings Results
Oscar Health reported quarterly earnings results, which are detailed in the attached press release and available for investor review regarding the company's operational performance and financial condition.
May 6
8-K · 7.01
! Medium
Oscar Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
Oscar Health reaffirmed its May 6, 2026 earnings release and conference call schedule, providing investors with advance notice of when to expect first-quarter results and management commentary.
Apr 21
8-K
Oscar Health, Inc. -- 8-K Filing
Oscar Health's 8-K filing contains standard forward-looking statement disclaimers, indicating investors should review risk factors in the company's 10-K before making investment decisions.
Mar 2
8-K · 1.01
! Medium
Oscar Health, Inc. -- 8-K 1.01: Financing / Debt Agreement
Oscar Health's revolving credit facility will mature on February 6, 2029, requiring the company to refinance or repay any outstanding borrowings by that date.
Feb 10
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 13,628,092 | $196M | Added | Dec 2025 |
| 2 | Vanguard Capital Management Llc | 10,777,627 | $124M | New | Mar 2026 |
| 3 | Vanguard Portfolio Management Llc | 10,545,848 | $121M | New | Mar 2026 |
| 4 | Jane Street Group, Llc | 5,781,826 | $83M | Added | Dec 2025 |
| 5 | Thrive Capital Management, Llc | 6,343,617 | $73M | — | Mar 2026 |
| 6 | Bit Capital Gmbh | 6,321,421 | $73M | Added | Mar 2026 |
| 7 | D.e. Shaw & Co | 5,485,285 | $63M | Reduced | Mar 2026 |
| 8 | Citadel Advisors Llc | 3,466,362 | $40M | Added | Mar 2026 |
| 9 | Point72 Asset Management | 3,113,671 | $36M | Added | Mar 2026 |
| 10 | Bank Of America Corp /de/ | 2,860,310 | $33M | Added | Mar 2026 |
| 11 | Susquehanna International Group, Llp | 2,745,804 | $31M | Added | Mar 2026 |
| 12 | Two Sigma Investments, Lp | 2,349,525 | $27M | Reduced | Mar 2026 |
| 13 | Bnp Paribas Financial Markets | 1,993,630 | $23M | Added | Mar 2026 |
| 14 | Northern Trust Corp | 1,877,284 | $22M | Added | Mar 2026 |
| 15 | Tudor Investment Corp | 1,720,794 | $20M | New | Mar 2026 |
| 16 | Ubs Group Ag | 1,574,978 | $18M | Added | Mar 2026 |
| 17 | State Of Michigan Retirement System | 1,450,000 | $17M | — | Mar 2026 |
| 18 | Jupiter Asset Management Ltd | 1,333,869 | $15M | New | Mar 2026 |
| 19 | Nuveen, Llc | 1,324,301 | $15M | Added | Mar 2026 |
| 20 | Assenagon Asset Management S.a. | 1,227,803 | $14M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$7.36B
Enterprise Value
$3.89B
P/E (TTM)
-16.80x
Forward P/E
47.15x
PEG Ratio
0.01x
P/B
7.60x
P/S
0.64x
P/FCF
7.04x
EV/EBITDA
—
Shares Out
262.4M
Financials (TTM)
Revenue
$11.70B
Net Income
-$443.2M
EBITDA
-$391.1M
Free Cash Flow
$1.06B
Op Cash Flow
$1.09B
EPS Basic
$-1.69
EPS Diluted
$-1.69
EPS Forward
$0.60
Gross Margin
14.4%
Op Margin
-3.4%
Net Margin
-3.8%
Balance Sheet
Total Assets
$6.33B
Total Liab.
$5.34B
Total Equity
$980.7M
Cash
$3.99B
LT Debt
$430.1M
Book Value/Sh
$3.74
Debt/Equity
0.44x
Current Ratio
0.95
Quick Ratio
0.95
Returns & Growth
ROE
-45.3%
ROA
-7.0%
ROIC
-27.1%
Rev Growth YoY
+27.5%
EPS Growth YoY
-1636.4%
Price Returns
2W
-4.0%
1M
+20.4%
3M
+63.0%
6M
+23.7%
12M
+61.1%
Technicals
52W High
$29.81
52W Low
$10.69
50d MA
$21.33
200d MA
$17.37
RSI (14)
71.30
ATR (14)
$1.82
Beta
1.93
Avg Volume
8.2M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$16.75
High
$18.00
Low
$15.00
Median
$17.00
Data updated apr 26, 2026 5:58pm
· Source: financialmodelingprep.com